Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Aditxt, Inc.
< Previous
1
2
Next >
Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic Plans
August 13, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
August 09, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
August 09, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian Cancer
August 07, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition
July 25, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
APLIF
OTC
TSX:APLI
Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing
July 17, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
EVFM
CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules
May 03, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
April 02, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
APLIF
TSX:APLI
Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications
January 30, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
January 08, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
January 05, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
January 02, 2024
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules
December 29, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
December 12, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
EVFM
Aditxt, Inc. to Present at 8th Annual Dawson James Conference
October 06, 2023
From
Aditxt, Inc.
Via
GlobeNewswire
Tickers
ADTX
Aditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me Platform
October 05, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (NASDAQ: ADTX) Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference September 11th-13th, 2023
September 08, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
September 06, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
August 31, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale
August 18, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
CORRECTING and REPLACING Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023
August 17, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc.’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics
June 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
May 05, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Issues Shareholder Update
April 17, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer
March 08, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.
March 03, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its President
February 14, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Forms Adimune, Inc. as a Wholly Owned Subsidiary with a Focus on Immune Modulation Therapies and Appoints Dr. Friedrich Kapp, Former President of the Therapeutic Business Unit at Schering AG, as its Chairman and CEO
January 03, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.